Susan Collins said...
We found that certain drug companies were putting their brand name drugs into restricted distribution systems.
Context
Collins highlights issues with brand drugs limiting access for generics.
09/20/2016
Collins highlights issues with brand drugs limiting access for generics.
09/20/2016